Fulcrum Therapeutics Inc
(NAS:FULC)
$
9.17
0.38 (4.32%)
Market Cap: 572.22 Mil
Enterprise Value: 308.09 Mil
PE Ratio: 0
PB Ratio: 2.09
GF Score: 53/100 - Q1 2024 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 13, 2024$7.35 (-1.61%)Earnings
- Q4 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptFeb 27, 2024$10.18 (+4.62%)Earnings
- Q3 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 07, 2023$4.29 (+19.50%)Earnings
- Q2 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 03, 2023$3.85 (+0.79%)Earnings
- Q1 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 15, 2023$3.64 (+11.31%)Earnings
- Q4 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 09, 2023$4.82 (-23.00%)Earnings
- Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Fulcrum Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 08, 2022$6.45 (+14.97%)Earnings
- Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 11, 2022$7.57 (-2.45%)Earnings
- Fulcrum Therapeutics Inc To Review Initial FTX-6058 Data And Provide Program Update Call TranscriptJun 10, 2022
- Fulcrum Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 09, 2022$7.66 (-11.24%)Earnings
- Fulcrum Therapeutics Inc To Discuss Unmet Need In FSHD, REACH Trial And Key Measures Of Disease Progression Call TranscriptMar 24, 2022
- Q4 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 03, 2022$11.7 (+5.41%)Earnings
- Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call TranscriptDec 06, 2021
- Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q3 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 04, 2021$21.15 (+3.27%)Earnings
- Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 10, 2021$18.77 (+125.33%)Earnings
- Fulcrum Therapeutics Inc Annual FSHD Society International Research Congress- Corporate Call TranscriptJun 24, 2021
- Fulcrum Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 06, 2021$10.58 (+5.06%)Earnings
- Q4 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 04, 2021$12.5 (-14.32%)Earnings
- Fulcrum Therapeutics, Inc. - Special Call TranscriptDec 15, 2020
- Q3 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 10, 2020$10.94 (+1.11%)Earnings
- Q2 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 11, 2020$8.9 (-48.01%)Earnings
- Fulcrum Therapeutics, Inc. - Special Call TranscriptJun 10, 2020
- Fulcrum Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 13, 2020$16.48 (+10.53%)Earnings
- Q4 2019 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 05, 2020$18.5 (+2.78%)Earnings
- Q3 2019 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 14, 2019$7.64 (-3.29%)Earnings
Fulcrum Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 08, 2022 / 02:10PM GMT
Release Date Price:
$6.14
Operator
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Tazeen Ahmad.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Great. Thanks, Joe. Good morning, everybody, and thanks for joining us again at the BofA Virtual SMID Biotech Conference. It's my pleasure to have our next presenting company, Fulcrum Therapeutics and presenting for Fulcrum for the next 30 minutes will be CEO, Bryan Stuart. Bryan, good morning. Thank you for joining us.
Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director
Yes. Good morning, Tazeen. Thanks for having us.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
All right. So we only have 30 minutes together today. So I think there's a lot going on at the company. So I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)